8-K Announcements
6Material company update
Mar 31, 2026·SEC
Material company update
Mar 20, 2026·SEC
Material company update
Nov 13, 2025·SEC
GoHealth, Inc.(GOCO)Earnings, Financials & Key Ratios
GOCO•NASDAQ•Insurance & Managed Care
Price updated Jun 19, 2026
SectorFinancial ServicesIndustryInsurance BrokersSub-IndustryDigital insurance marketplaces and brokers
AboutGoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and IFP and Other—External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.Show more
- Revenue$362M-54.7%
- Combined Ratio142.27%+41.0%
- Net Income-$257M-8681.6%
- Return on Equity-113.5%-17601.4%
- Medical Cost Ratio26.57%+62.5%
- Operating Margin-42.27%-4691.6%
- Net Margin-71.06%-19288.4%
- ROA-20.77%-10497.5%
- Equity / Assets-0.54%-101.7%
GOCO Key Insights
GoHealth, Inc. (GOCO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Low loss ratio of 26.6%
✗Weaknesses
- ✗Unprofitable underwriting: 142.3% combined ratio
- ✗Profits declining 42.2% over 5 years
- ✗Weak Piotroski F-Score: 2/9
- ✗Weak momentum: RS Rating 1 (bottom 1%)
- ✗Shares diluted 29.7% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GOCO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GOCO Price & Volume
GoHealth, Inc. (GOCO) stock price & volume — 10-year historical chart
Loading chart...
GOCO Growth Metrics
GoHealth, Inc. (GOCO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-16.23%
3 Years-16.95%
TTM-81.69%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-15519.63%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-1730.16%
Return on Capital
10 Years-5.64%
5 Years-13.52%
3 Years-7.47%
Last Year-15.32%
GOCO Recent Earnings
GoHealth, Inc. (GOCO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 18, 2026Metric
Actual
Est
EPS
$2.36+1.7%
$2.40
Rev
$12M-29.5%
$17M
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$1.03+61.7%
$2.69
Rev
$13M-85.7%
$89M
Q4 2025
Nov 13, 2025Metric
Actual
Est
EPS
$0.19+90.8%
$2.06
Rev
$34M-61.4%
$89M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$1.23+52.7%
$2.60
Rev
$94M-18.4%
$115M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 18, 2026 | $2.36vs $2.40+1.7% | $12Mvs $17M-29.5% |
| Q2 2026 | Mar 31, 2026 | $1.03vs $2.69+61.7% | $13Mvs $89M-85.7% |
| Q4 2025 | Nov 13, 2025 | $0.19vs $2.06+90.8% | $34Mvs $89M-61.4% |
| Q3 2025 | Aug 7, 2025 | $1.23vs $2.60+52.7% | $94Mvs $115M-18.4% |
Based on last 12 quarters of dataView full earnings history →
GOCO Peer Comparison
GoHealth, Inc. (GOCO) competitors in Digital insurance marketplaces and brokers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SLQT | 174.25M | 0.99 | 74.32 | 15.5% | 4.45% | 12.16% | 0.72 | |
 EHTH | 51.27M | 1.65 | -4.85 | 4.06% | 6.31% | 3.99% | 0.14 | |
 EHC | 9.75B | 98.03 | 17.69 | 10.46% | 10.04% | 18.86% | 0.83 | |
 ACHC | 2.29B | 24.87 | -2.05 | 5.04% | -32.84% | -40.92% | 1.24 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 | |
 HUM | 43.3B | 360.65 | 36.65 | 10.06% | 0.82% | 6.17% | 0.73 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 |
Compare GOCO vs Peers
GoHealth, Inc. (GOCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GOCO Income Statement
GoHealth, Inc. (GOCO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 226.21M | 539.5M | 877.35M | 1.06B | 631.67M | 734.67M | 798.89M | 361.85M | 152.79M |
Revenue Growth % | - | 138.5% | 62.62% | 21.09% | -40.54% | 16.31% | 8.74% | -54.71% | -81.69% |
Medical Costs & Claims | 79.58M | 169.55M | 199.2M | 239.34M | 187.67M | 158.96M | 130.61M | 96.13M | 55.96M |
Medical Cost Ratio % | 35.18% | 31.43% | 22.7% | 22.53% | 29.71% | 21.64% | 16.35% | 26.57% | 36.63% |
Gross Profit | 146.62M▲ 0% | 369.95M▲ 152.3% | 678.15M▲ 83.3% | 823.08M▲ 21.4% | 444M▼ 46.1% | 575.71M▲ 29.7% | 668.28M▲ 16.1% | 265.72M▼ 60.2% | 96.83M▲ 0% |
Gross Margin % | 64.82% | 68.57% | 77.3% | 77.47% | 70.29% | 78.36% | 83.65% | 73.43% | 63.37% |
Gross Profit Growth % | - | 152.31% | 83.31% | 21.37% | -46.06% | 29.66% | 16.08% | -60.24% | - |
Operating Expenses | 117.86M | 402.73M | 742.69M | 1.31B | 762.67M | 657.39M | 675.33M | 418.66M | 551.19M |
OpEx / Revenue % | 52.1% | 74.65% | 84.65% | 123.54% | 120.74% | 89.48% | 84.53% | 115.7% | 360.76% |
Depreciation & Amortization | 6.16M | 29.89M | 98.55M | 107.51M | 107M | 105.75M | 105.89M | 80.11M | 53.94M |
Combined Ratio % | 87.28% | 106.08% | 107.36% | 146.07% | 150.45% | 111.12% | 100.88% | 142.27% | 397.38% |
Operating Income | 28.76M▲ 0% | -32.78M▼ 214.0% | -64.55M▼ 96.9% | -489.45M▼ 658.3% | -318.67M▲ 34.9% | -81.68M▲ 74.4% | -7.05M▲ 91.4% | -152.94M▼ 2070.3% | -454.36M▲ 0% |
Operating Margin % | 12.72% | -6.08% | -7.36% | -46.07% | -50.45% | -11.12% | -0.88% | -42.27% | -297.38% |
Operating Income Growth % | - | -213.96% | -96.92% | -658.29% | 34.89% | 74.37% | 91.37% | -2070.29% | - |
EBITDA | 34.92M | -2.89M | 34.01M | -381.94M | -211.66M | 24.07M | 98.84M | -72.83M | -400.43M |
EBITDA Margin % | 15.44% | -0.54% | 3.88% | -35.95% | -33.51% | 3.28% | 12.37% | -20.13% | -262.08% |
Interest Expense | 224K | 8.22M | 32.97M | 33.51M | 57.07M | 69.47M | 72.87M | 87.32M | 102.15M |
Non-Operating Income | 379K | -79.21M | -358K | 11.27M | -115K | -37K | -74.86M | 260.83M | 1.31M |
Pretax Income | 28.16M▲ 0% | 41.09M▲ 45.9% | -97.16M▼ 336.4% | -534.22M▼ 449.9% | -375.62M▲ 29.7% | -151.12M▲ 59.8% | -5.05M▲ 96.7% | -501.09M▼ 9818.6% | -557.83M▲ 0% |
Pretax Margin % | 12.45% | 7.62% | -11.07% | -50.28% | -59.46% | -20.57% | -0.63% | -138.48% | -365.1% |
Income Tax | 46K | 22K | 43K | -24K | 764K | 154K | 2.27M | -3.33M | -3.73M |
Effective Tax Rate % | 0.16% | 0.05% | -0.04% | 0% | -0.2% | -0.1% | -44.87% | 0.67% | 0.67% |
Net Income | 28.12M▲ 0% | -41.07M▼ 246.1% | -44.27M▼ 7.8% | -189.36M▼ 327.8% | -148.71M▲ 21.5% | -63.26M▲ 57.5% | -2.93M▲ 95.4% | -257.13M▼ 8681.6% | -289.89M▲ 0% |
Net Margin % | 12.43% | -7.61% | -5.05% | -17.82% | -23.54% | -8.61% | -0.37% | -71.06% | -189.73% |
Net Income Growth % | - | -246.06% | -7.79% | -327.76% | 21.47% | 57.46% | 95.37% | -8681.63% | -15519.63% |
EPS (Diluted) | 1.34▲ 0% | -1.96▼ 246.3% | -3.30▼ 68.4% | -26.85▼ 713.6% | -17.72▲ 34.0% | -7.19▲ 59.4% | -0.66▲ 90.8% | -20.17▼ 2956.1% | -17.90▲ 0% |
EPS Growth % | - | -246.27% | -68.37% | -713.64% | 34% | 59.42% | 90.82% | -2956.06% | -1730.16% |
EPS (Basic) | 1.34 | -1.96 | -3.30 | -26.85 | -17.72 | -7.19 | -0.66 | -20.17 | - |
Diluted Shares Outstanding | 20.91M | 20.91M | 5.61M | 7.07M | 8.45M | 9.29M | 9.98M | 12.94M | 16.2M |
GOCO Balance Sheet
GoHealth, Inc. (GOCO) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Assets | 142.84M | 1.6B | 2.11B | 2.07B | 1.66B | 1.5B | 1.49B | 987.38M | 917.92M |
Asset Growth % | - | 1021.76% | 31.61% | -1.89% | -19.8% | -9.63% | -0.74% | -33.66% | -86.12% |
Total Investment Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 54.03M | 143.77M | 391.82M | 429M | 414.56M | 476.44M | 400.41M | 285.79M | 264.9M |
Cash & Equivalents | 505K | 12.28M | 144.23M | 84.36M | 16.46M | 90.81M | 40.92M | 32.9M | 39.88M |
Receivables | 48.54M | 125.54M | 215.24M | 285.94M | 340.5M | 336.46M | 324.85M | 239.72M | 1.56B |
Other Current Assets | 0 | 0 | 3.4M | 0 | 57.59M | 49.17M | 34.64M | 13.17M | -627.36M |
Goodwill & Intangibles | 0 | 1.17B | 1.08B | 594.67M | 500.61M | 396.55M | 302.5M | 0 | 202.47M |
Goodwill | 0 | 386.55M | 386.55M | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 782.78M | 688.73M | 594.67M | 500.61M | 396.55M | 302.5M | 0 | 0 |
PP&E (Net) | 11.78M | 6.34M | 17.35M | 47.73M | 46.77M | 48.84M | 48.64M | 14.77M | 13.94M |
Other Assets | -65.81M | 282.85M | 624.34M | 997.45M | 697.36M | 577.74M | 736.88M | 686.82M | 639.08M |
Total Liabilities | 329.49M | 742.15M | 709.64M | 1.18B | 1.07B | 1.04B | 1.03B | 992.7M | 1.04B |
Total Debt | 5.01M | 291.65M | 400.57M | 696.29M | 557.42M | 543.05M | 527.97M | 672.59M | 746.03M |
Net Debt | 4.5M | 279.38M | 256.34M | 611.93M | 540.96M | 452.24M | 487.05M | 639.69M | 706.15M |
Long-Term Debt | 0 | 288.23M | 396.4M | 665.12M | 504.81M | 422.7M | 447.87M | 636.74M | 708.67M |
Short-Term Debt | 4.86M | 3M | 4.17M | 5.27M | 5.27M | 75M | 39.5M | 0 | 2.38M |
Total Current Liabilities | 47.98M | 113.06M | 127.37M | 217.07M | 265.45M | 370.01M | 338.05M | 141.5M | 10.56M |
Accounts Payable | 28.87M | 69.58M | 8.73M | 144M | 137.17M | 144.97M | 113.36M | 70.87M | 8.47M |
Deferred Revenue | 1.36M | 15.22M | 0 | 536K | 50.59M | 52.4M | 53.72M | 25.49M | 23.79M |
Other Current Liabilities | 3.18M | 2.69M | 9.06M | 8.34M | 10.11M | 5.59M | 4.42M | 3.33M | -32.26M |
Deferred Taxes | 226K | 243K | 0 | 0 | 0 | 0 | 1000K | 1000K | 83.35M |
Other Liabilities | 28K | 340.19M | 185.87M | 274.4M | 258.96M | 212.35M | 186.86M | 167.18M | 255.54M |
Total Equity | -182.15M▲ 0% | 860.14M▲ 572.2% | 1.4B▲ 62.7% | 892.49M▼ 36.2% | 591.7M▼ 33.7% | 454.95M▼ 23.1% | 458.4M▲ 0.8% | -5.32M▼ 101.2% | -126.7M▲ 0% |
Equity Growth % | - | 572.22% | 62.67% | -36.21% | -33.7% | -23.11% | 0.76% | -101.16% | -328.78% |
Shareholders Equity | -186.65M | 860.14M | 380.42M | 353.1M | 318.06M | 280.32M | 294.8M | 94.76M | 2.13M |
Minority Interest | 4.5M | 0 | 1.02B | 539.39M | 273.64M | 174.64M | 163.6M | -100.08M | -128.83M |
Retained Earnings | -189.1M | 0 | -18.8M | -208.32M | -357.02M | -420.28M | -423.21M | -680.33M | -717.5M |
Common Stock | 2.44M | 0 | 32K | 2K | 2K | 2K | 2K | 2K | 2K |
Accumulated OCI | 14K | -17K | 17K | -59K | -144K | -127K | -151K | -59K | -51K |
Return on Equity (ROE) | - | -12.11% | -3.92% | -16.53% | -20.04% | -12.09% | -0.64% | -113.5% | -462.09% |
Return on Assets (ROA) | 19.68% | -4.71% | -2.39% | -9.07% | -7.98% | -4.01% | -0.2% | -20.77% | -27.3% |
Equity / Assets | -127.52% | 53.68% | 66.35% | 43.14% | 35.66% | 30.34% | 30.8% | -0.54% | -13.8% |
Debt / Equity | - | 0.34x | 0.29x | 0.78x | 0.94x | 1.19x | 1.15x | - | -5.89x |
Book Value per Share | -8.71 | 41.14 | 249.29 | 126.31 | 70.07 | 48.96 | 45.93 | -0.41 | -7.82 |
Tangible BV per Share | -8.71 | -14.79 | 57.71 | 42.15 | 10.79 | 6.29 | 15.62 | -0.41 | -7.82 |
GOCO Cash Flow Statement
GoHealth, Inc. (GOCO) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 5.44M | -3K | -114.22M | -299.01M | 60.9M | 109.14M | -21.61M | -121.95M | -102.13M |
Operating CF Growth % | - | -100.06% | -3807133.33% | -161.79% | 120.37% | 79.2% | -119.8% | -464.39% | -378.38% |
Operating CF / Revenue % | 2.41% | -0% | -13.02% | -28.14% | 9.64% | 14.86% | -2.7% | -33.7% | -66.84% |
Net Income | 28.11M | -41.07M | -97.2M | -534.19M | -376.38M | -151.27M | -7.32M | -257.13M | -289.89M |
Depreciation & Amortization | 6.16M | 32.98M | 98.55M | 107.51M | 107M | 105.75M | 105.89M | 80.11M | 53.94M |
Stock-Based Compensation | 0 | 0 | 216.23M | 27.3M | 27.14M | 19.55M | 11.28M | 9.17M | 2.87M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 4.48M | -3.76M | -4.82M |
Other Non-Cash Items | 791K | 159.25M | 20.44M | 406.8M | 32.98M | 19M | -61.04M | 70.52M | 155.3M |
Working Capital Changes | -29.62M | -151.17M | -352.24M | -306.42M | 270.16M | 116.12M | -74.9M | -20.86M | 67.66M |
Cash from Investing | -6.17M | -815.61M | -14.52M | -19.8M | -13.51M | -13.73M | 3.81M | -8.25M | -5.2M |
Capital Expenditures | -6.17M | -8.02M | -14.52M | -19.8M | -13.51M | -13.73M | -13.73M | -8.25M | -5.2M |
Acquisitions | 0 | -807.59M | 0 | 0 | 0 | 0 | 17.54M | 0 | 0 |
Purchase of Investments | 0 | 0 | -508.32M | 0 | 0 | 0 | 0 | 0 | 0 |
Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing | 0 | 0 | 508.32M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 63K | 827.43M | 260.66M | 259.09M | -115.05M | -21.11M | -32.03M | 122M | 124.74M |
Dividends Paid | 0 | 0 | -400K | 0 | 0 | -3.57M | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | -345K | -2.29M | -1.51M | -5.22M | -4.32M |
Stock Issued | 0 | 541.26M | 862.41M | 0 | 0 | 0 | 0 | 1K | 0 |
Debt Issuance (Net) | 142K | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K | 1000K | 3M |
Other Financing | -79K | 0 | -614.17M | -6.62M | -4.33M | 91K | -32.73M | -8.41M | -8.94M |
Net Change in Cash | -667K▲ 0% | 11.77M▲ 1864.8% | 131.96M▲ 1021.0% | -59.87M▼ 145.4% | -67.9M▼ 13.4% | 74.34M▲ 209.5% | -49.89M▼ 167.1% | -8.02M▲ 83.9% | 17.73M▲ 0% |
Exchange Rate Effect | -3K | -49K | 35K | -155K | -238K | 42K | -55K | 182K | 315K |
Cash at Beginning | 1.17M | 505K | 12.28M | 144.23M | 84.36M | 16.46M | 90.81M | 40.92M | 32.9M |
Cash at End | 505K | 12.28M | 144.23M | 84.36M | 16.46M | 90.81M | 40.92M | 32.9M | 39.88M |
Free Cash Flow | -727K▲ 0% | -8.02M▼ 1003.0% | -128.74M▼ 1505.4% | -318.81M▼ 147.6% | 47.39M▲ 114.9% | 95.41M▲ 101.3% | -35.34M▼ 137.0% | -130.19M▼ 268.4% | -107.33M▲ 0% |
FCF Growth % | - | -1003.03% | -1505.44% | -147.64% | 114.87% | 101.32% | -137.04% | -268.45% | -82.7% |
FCF Margin % | -0.32% | -1.49% | -14.67% | -30.01% | 7.5% | 12.99% | -4.42% | -35.98% | -70.24% |
FCF per Share | -0.03 | -0.38 | -22.94 | -45.12 | 5.61 | 10.27 | -3.54 | -10.06 | -6.63 |
GOCO Key Ratios
GoHealth, Inc. (GOCO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Combined Ratio | 106.08% | 107.36% | 146.07% | 150.45% | 111.12% | 100.88% | 142.27% | 397.38% |
Medical Cost Ratio | 31.43% | 22.7% | 22.53% | 29.71% | 21.64% | 16.35% | 26.57% | 36.63% |
Return on Equity (ROE) | -12.11% | -3.92% | -16.53% | -20.04% | -12.09% | -0.64% | -113.5% | -462.09% |
Return on Assets (ROA) | -4.71% | -2.39% | -9.07% | -7.98% | -4.01% | -0.2% | -20.77% | -27.3% |
Equity / Assets | 53.68% | 66.35% | 43.14% | 35.66% | 30.34% | 30.8% | -0.54% | -13.8% |
Book Value / Share | 41.14 | 249.29 | 126.31 | 70.07 | 48.96 | 45.93 | -0.41 | -7.82 |
Debt / Equity | 0.34x | 0.29x | 0.78x | 0.94x | 1.19x | 1.15x | - | -5.89x |
Revenue Growth | 138.5% | 62.62% | 21.09% | -40.54% | 16.31% | 8.74% | -54.71% | -81.69% |
Related:GOCO Dividend History·GOCO Revenue History·GOCO Price History·GOCO P/E History·GOCO Financial Ratios·GOCO Institutional Holders
GOCO SEC Filings & Documents
GoHealth, Inc. (GOCO) SEC filings — annual & quarterly reports (10-K, 10-Q)
GOCO Frequently Asked Questions
GoHealth, Inc. (GOCO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
GoHealth, Inc. (GOCO) saw revenue decline by 54.7% over the past year.
GoHealth, Inc. (GOCO) reported a net loss of $289.9M for fiscal year 2025.
Dividend & Returns
GoHealth, Inc. (GOCO) has a return on equity (ROE) of -113.5%. Negative ROE indicates the company is unprofitable.
Industry Metrics
GoHealth, Inc. (GOCO) has a combined ratio of 142.3%. A ratio above 100% means claims and expenses exceed premiums.